FIELD: chemistry.
SUBSTANCE: invention relates to novel N-(2-acetamidopurin-6-yl)glycine of lower given formula 
, which has anti-tuberculosis activity, including with respect to strains of mycobacteria with multi-drug-resistance. Invention can be applied in medicine and veterinary.
EFFECT: increase of compound activity.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| N-(2-AMINOPURIN-6-YL)GLYCYL-(S)-GLUTAMIC ACID, HAVING ANTI-TUBERCULOSIS ACTIVITY | 2015 |
|
RU2604068C1 |
| 1-ETHYL-6-FLUORO-4-OXO-7-(8-ETHOXY-2-OXO-2H-CHROMEN-3-YL)-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID WITH ANTI-TUBERCULAR ACTIVITY | 2017 |
|
RU2642426C1 |
| 5-FLUORO-2-(4-ETHOXYCARBONYLDIPIPERAZINE-1-YL)-1,3-BENZOTHIAZINE-4-ONE, WHICH HAS ANTI-TUBERCULOSIS ACTIVITY | 2018 |
|
RU2663848C1 |
| α,ω-BIS(AMIDE- AND HYDRAZIDE METHYL SULFINYL- AND SULPHONYL) ALKANES HAVING ANTI-TUBERCULOSIS ACTIVITY, AND α,ω-BIS(METHOXY CARBONYL METHYL SULFINYL- OR SULPHONYL) ALKANES FOR PRODUCTION THEREOF | 2015 |
|
RU2591256C1 |
| TRAIZINES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2010 |
|
RU2431633C1 |
| SELECTIVE ANTI-TUBERCULOSIS AGENTS, REPRESENTING 3-AMINOSUBSTITUTED 6-(3,5-DIMETHYLPYRAZOL-1-YL)-1,2,4,5-TETRAZINES | 2012 |
|
RU2519218C2 |
| SELECTIVE ANTITUBERCULOSIS AGENT REPRESENTING 3-HYDRAZONO-6-(3,5-DIMETHYLPYRAZOL-1-YL)- 1,2,4,5-TETRAZINE AND METHOD FOR PREPARING IT | 2011 |
|
RU2479311C2 |
| ANTITUBERCULAR AGENT BASED ON A PYRIDOXINE DERIVATIVE | 2021 |
|
RU2772219C1 |
| SILVER SALTS OF 1-ARYL-4,4,4-TRIFLUOROBUTANE-1,3-DIONES, EXHIBITING TUBERCULOSTATIC ACTIVITY | 2023 |
|
RU2817114C1 |
| ANTI-TUBERCULOSIS AGENTS BEING 3,7-DISUBSTITUTED [1,2,4]TRIAZOLO[1,5-b][1,2,4,5]TETRAZINES | 2022 |
|
RU2802300C1 |
